Mark Berman

Dr. Mark Berman is Chief Medical Officer of Better Therapeutics. Previously, he practiced as an internal and lifestyle medicine physician at One Medical. Dr. Berman received his M.D. from Yale. He completed residency at Harvard’s Brigham and Women’s Hospital and a clinical research fellowship at University of California, San Francisco. He has also served as a director of the American College of Lifestyle Medicine.

Posts by Mark Berman

Diabetes care needs to support lifestyle changes – not pharmaceutical intervention – first

While pharmaceuticals are a critical piece of the treatment landscape for type 2 diabetes, they have been the exclusive and de-facto first-line treatment for too long. Prescription digital therapeutics can and should be considered as part of type 2 diabetes therapies.